CHAPTER 62  CENTRAL NERVOUS SYSTEM
                    SCINTIGRAPHY

DAVID H. LEWIS AND JON UMLAUF

2-D (Planar Brain Scans)
Cerebrospinal Fluid Studies
Cerebral Perfusion Imaging
Positron Emission Tomography
Single-Photon Emission Computed
Tomography

    2-D (PLANAR BRAIN SCANS)                                       the BBB. This finding is entirely nonspecific, being present in
                                                                   conditions as diverse as cerebral infarction, primary or meta-
Before the advent of CT, the planar nuclear medicine brain         static tumor, and infectious processes. For this reason, clinical
scan, using radiopharmaceuticals such as Technetium-               information is essential for interpretation. The presence of a
99metastable (Tc-99m) diethylenetriaminepentaacetic acid           lenticular photo-enhanced (or occasionally photopenic) rim
(DTPA) or Tc-99m-glucoheptonate (GH), was used to detect           can be used to diagnose subdural hematoma.
a breakdown in the blood-brain barrier (BBB). Currently, pla-
nar brain imaging using agents that cross the intact blood             The normal radionuclide angiogram is characterized by
brain barrier, such as Tc-99m-hexamethylpropyleneamine             prompt symmetric perfusion. Asymmetric flow in the carotid
oxime (HMPAO) or Tc-99m-ethyl cysteinate dimer (ECD),              arteries may indicate occlusive disease. The so-called flip-flop
can detect absence of cerebral blood flow, which is character-     sign (decreased activity in the arterial phase and increased
istic of brain death. The normal blood brain barrier protects      activity in the venous phase) may be seen in carotid occlu-
the CNS by preventing entry of harmful substances. Most            sion. Vascular malformations, high-grade or vascular tumors,
materials are excluded from the CNS on the basis of molecu-        such as glioblastoma multiforme and meningioma, and inflam-
lar size and chemical characteristics. Active transport mecha-     matory processes have increased flow. Low-grade or benign
nisms are present for certain key nutrients such as glucose.       tumors, areas of porencephaly or edema, and occlusive pro-
                                                                   cesses have decreased flow. The complete absence of brain
    Radiopharmaceutical. Planar brain scanning for the             activity, including the cerebellum, in the presence of prompt
detection of the BBB breakdown is typically performed with         common carotid and scalp flow is consistent with brain death.
either Tc-99m bound to DTPA or GH. Any agent that does
not normally cross the blood brain barrier can potentially be          The traditional brain scan with Tc-99m-DTPA or GH has
employed, although agents of cellular size (e.g., radiolabeled     largely been superseded by planar perfusion brain scans in clini-
red blood cells) will be excluded even by a damaged blood          cal practice to corroborate the impression of brain death. There
brain barrier.                                                     is little doubt that modern brain radiopharmaceuticals such as
                                                                   Tc-99m HMPAO or ECD provide with greater assurance, the
    Technique. A dose of 15 to 20 mCi of Tc-99m-DTPA or            status of cerebral blood flow. These scans are also much easier
GH is injected into an arm vein. Flow images are typically         to interpret although more costly to perform due to the higher
obtained at a rate of one image every 3 seconds for a total of     expense of the radiopharmaceuticals employed. Total cessation
60 seconds, with the camera anterior to the head. Anterior,        of the cerebral blood flow including posterior fossa structures
posterior, and lateral static images are subsequently obtained;    can be demonstrated with this technique, which is required by
vertex images are often useful. These are obtained by placing      the Uniform Determination of Death Act. (National Confer-
the camera at the vertex of the skull. A lead collar is employed   ence of Commissioners on Uniform State Laws, 1981) (1).
to exclude radiation from the radiopharmaceutical localized
below the neck. Immediate static images are useful to evaluate         Brain Death. Criteria for Tc-99m brain perfusion radio-
blood pool abnormalities, whereas delayed static images after      pharmaceutical planar scanning has been retrospectively
clearance of the background activity are of greater value to       validated (2). Brain perfusion agents have advantages over
detect breakdown of the blood brain barrier.                       conventional agents such as Tc-99m-GH or Tc-99m-DTPA
                                                                   and are not as dependent on the quality of bolus injection,
    Interpretation. Interpretation of the static images depends    are easier to interpret, and allow evaluation of posterior fossa
primarily on detecting or excluding radiopharmaceutical            blood flow (3,4). Radionuclide cerebral angiography without
localization within the brain parenchyma. Some activity is         brain perfusion radiopharmaceuticals requires rapid acquisi-
invariably present from the radiopharmaceutical within the         tion of dynamic images in technically challenging situations
soft tissues of the scalp and within intracerebral blood vessels.  and cannot image flow in posterior fossa. Interpretation may
Increased or asymmetric localization indicates breakdown of        be difficult or equivocal.

                                                                                                                                    1373
1374  Section Twelve: Nuclear Radiology

A                                                                    B

FIGURE 62.1. Brain Perfusion Planar Scans for Brain Death. A. Planar scan demonstrates uptake in brain parenchyma and therefore does not
meet Nuclear Medicine criteria for the corroboration of the clinical impression of brain death. B. Absence of uptake in brain and therefore meets
criteria for the corroboration of the clinical impression of brain death by total absence of cerebral blood flow.

    Radionuclide scintigraphy is not affected by drug intoxica-      radiopharmaceutical ascends to the basilar cisterns in approxi-
tion, hypothermia, or hypovolemia; however, these conditions         mately 4 hours and flows over the convexities within 24 hours
do affect the clinical assessment of brain death. In the pres-       in a normal individual. Images of the basilar cisterns are
ence of brain death, the radioactive bolus stops at the base         obtained at 4 to 6 hours. If images at 24 hours show ascent
of the skull because of increased intracranial pressure that         over the convexities with activity in the interhemispheric fis-
exceeds cerebral perfusion pressure. It is important to have a       sure and relative clearance of the basilar cisterns, imaging may
good bolus injection, and if distinct activity is not identified in  be terminated. Otherwise, images should be obtained at 48
the common carotid artery, the injection should be repeated.         and 72 hours (5).
Absence of intracerebral arterial flow and no visualization of
major venous sinuses on subsequent static images support a               Application to Hydrocephalus. Standard cisternography is
diagnosis of brain death (Fig. 62.1). The "hot nose sign," due       performed primarily to evaluate for normal pressure hydro-
to increased collateral blood flow in the nasal area, could be       cephalus and for CSF leak. Normal pressure hydrocephalus
a secondary sign in brain death, but is considered nonspecific.      is a form of communicating hydrocephalus clinically associ-
                                                                     ated with ataxia, dementia, and urinary incontinence. Cister-
 CEREBROSPINAL FLUID STUDIES                                         nography demonstrates early localization of activity within
                                                                     the lateral ventricles, persisting beyond 24 hours and delayed
Cerebrospinal fluid (CSF) is formed in the choroid plexus as         clearance over the convexities (Fig. 62.2). Although these find-
an ultrafiltrate of plasma. It flows from the ventricles through     ings indicate an increased likelihood of a clinical response to
the foramina of the fourth ventricle and ascends over the con-       shunting, they are not univariate predictors of outcome (6).
vexities of the brain to be absorbed by the arachnoid villa.         Other forms of communicating hydrocephalus (such as might
Processes that impede flow over the convexities or absorption        result from radiation therapy or intrathecal chemotherapy)
of the fluid by the villi result in communicating hydrocepha-        can also be evaluated with cisternography.
lus. Tracer techniques are ideal for imaging of this process,
because they are injected in small amounts and do not alter              Application to CSF Leak. Cisternography has high sensi-
the CSF flow. Processes that obstruct the outflow from a ven-        tivity for CSF leak and remains the procedure of choice for
tricle are more difficult to assess by these techniques because      this condition. The sensitivity results from the ability of tracer
injection can be made directly into the ventricle. Patency and       technique to detect very small amounts of activity that may be
flow in the therapeutic shunts and reservoirs can easily be          intermittently leaking. Imaging is performed between 1 and
evaluated by injecting the tracer directly into the device.          3 hours after injection and also at 24 and perhaps 48 hours.
                                                                     Patient and camera position are chosen to maximize the likeli-
    Radiopharmaceuticals and Technique. The standard cis-            hood of detection, with lateral views for CSF rhinorrhea and
ternogram is performed by intrathecal injection of a sterile,        anterior views for CSF otorrhea. Cotton pledgets should be
pyrogen-free radiopharmaceutical. The only approved agent            placed in the nostrils after intrathecal injection of tracer. These
currently marketed for this purpose is Indium (In)-111 DTPA          are counted at 4 to 6 hours in a well counter. A serum sample
(half-life = 2.8 days). The injection of 0.5 mCi follows a spi-      from peripheral blood drawn concurrently is also counted.
nal tap performed in the standard manner. Initial images may         Pledget activity exceeding 1.5 times the serum concentration is
be obtained to ensure intrathecal injection. Subsequently, the       evidence for CSF rhinorrhea (7). However, because this imag-
                                                                     ing method does not give morphologic information about the
                                                                     leakage, DiChiro et al. suggested use of imaging as well (8).
                                                                     Chapter 62: Central Nervous System Scintigraphy  1375

FIGURE 62.2. Normal Pressure
Hydrocephalus on Cisternogram.
Selected images from an In-111 dieth-
ylenetriaminepentaacetic acid cister-
nogram in lateral views shown at 4 to
6 hours, 24 hours, and 48 hours.
Abnormal uptake is seen in lateral
ventricles, which persists through 48
hours.

    Application to Shunts and Reservoirs. CSF shunt and res-         shunt system. A T1/2 of clearance from the reservoir can be cal-
ervoir studies are performed by direct injection of radiotracer      culated and should usually be less than 8 minutes (9). If the
into the device. The demonstration of a patent ventriculo-           CSF flow is disturbed and opening pressure is low, the blockage
peritoneal, ventriculoatrial, or ventriculopleural shunt is an       is in the proximal limb. If opening pressure is high (more than
important study for neurosurgeons contemplating shunt revi-          20 cm H2O), the obstruction is distal to the reservoir.
sion. Ommaya reservoirs for delivering chemotherapy can be
evaluated in this manner as well.                                        In instances of distal malfunction of the shunt system, the
                                                                     clearance curve is flat and the half-time clearance of the reser-
    Radiopharmaceuticals and Technique. While In-111 DTPA            voir indicates infinite values. For complete distal obstruction
and Tc-99m-DTPA are acceptable agents, Tc-99m-pertechne-             or rupture of abdominal catheter, the isotope fails to migrate
tate can also be used. A small volume of radiopharmaceutical         through the tubing, whereas in partial distal obstruction due to
such as 0.1 to 0.2 mCi Tc-99m-pertechnetate in 0.1 mL of             relatively high abdominal pressure or obstruction of the valve,
normal saline is typically administered. Maintenance of sterile      extremely low radionuclide clearance is encountered. Perito-
techniques during the injection is critical. It is also critical to  neal loculations are typically characterized by stagnation of
understand the specific device being evaluated, as shunts often      radioactivity at initial site of appearance within the abdominal
contain check valves and reservoir capacities with various           cavity and absence of uniform diffusion in the peritoneum.
specifications. A patient may also have several shunt tubes,
some of which may be known to be occluded. In general, it                Demonstration of shunt patency depends on many factors,
is best to have direct input from the neurosurgeon involved          including patient's CSF production, proportion of CSF circu-
in the case to ensure that the maximum amount and correct            lating through normal pathways, resting intraventricular pres-
information is obtained. The shunt reservoir can be accessed         sure, patient's position before the test, opening pressure of the
using a butterfly needle and the opening pressure of the CSF         shunt system, length of tubing, and variations of intraventricu-
obtained. Then, using the same tubing, a small amount of CSF,        lar pressure due to coughing, straining, or crying.
up to 0.5 to 1 cc may be withdrawn for lab studies before the
tracer injection. Before injection of the radiotracer, the patient       Demonstration of proximal limb flow is not necessary to
is moved under the camera. Dynamic gamma camera imaging              prove shunt patency (10). Inability to measure intraventricular
for 10 minutes is usually first performed in the supine posi-        pressure, to aspirate CSF freely, or to inject the isotope into the
tion. If radiotracer drains from the reservoir, then in cases of     ventricle was considered of some help in assessing proximal
ventriculoperitoneal shunts, an abdominal image is obtained.         shunt obstruction.
If the shunt leads elsewhere, such as atrium, images of thyroid
and chest are done. When there is lack of spontaneous drain-             Overshunting is also described when the opening pressure
age in the supine position, provocative drainage maneuvers           is low and T1/2 in the supine position is less than 1 minute.
such as sitting the patient upright, walking the patient for 1       Overshunting may be an indication for shunt valve adjustment
to 2 minutes, or pumping the shunt reservoir 3 to 5 times may        or possibly shunt revision. Typically, patients with overshunt-
demonstrate shunt patency. When shunt patency requires pro-          ing have headache that progresses in severity from morning
vocative maneuvers, the shunt function may be described as           to evening.
positional. Positional shunts have occasionally been found to
be obstructed at revision.                                            CEREBRAL PERFUSION IMAGING

    Shunts are evaluated primarily for patency. If the proximal      Cerebral perfusion imaging is one of many recent advances in
portion is occluded manually (or contains a check valve), flow       functional neuroimaging. Anatomic studies fail to provide
through the distal limb can be evaluated. The tracer should flow     functional information that can be used to localize variations
freely into the peritoneum (for ventriculoperitoneal shunts).        in regional blood flow that define many disease states.
Delayed flow or persistent activity at the shunt tip suggests        Radiopharmaceuticals used to study regional cerebral blood
malfunction. Diffusion into the peritoneum confirms a patent         flow must have three properties to be effective. They must
                                                                     cross the blood-brain barrier, their extraction ratio must be
1376  Section Twelve: Nuclear Radiology

very high, and largely stable at varying rates of flow so that      of functional brain imaging. For this reason, the technique
their initial distribution will be proportional to regional cere-   and interpretation of these studies is not discussed in detail.
bral blood flow, and they must be retained within the brain in      The interested reader is referred to one of the many excellent
their initial distribution long enough for statistically valid      reviews available for PET brain imaging (16).
tomographic images to be obtained. The radiotracers are lipo-
philic to cross the BBB by passive diffusion with nearly com-            SINGLE-PHOTON EMISSION
plete first pass extraction in the brain. The agents in widespread      COMPUTED TOMOGRAPHY
use for SPECT imaging are Tc-labeled agents such HMPAO
and ECD. The PET agent most commonly used for brain                 Radiopharmaceuticals. Much of the early work in this area
blood flow is O-15 water that has a 2-minute T1/2 that requires     was performed with Xe-133. This inhaled gas dissolves in
an onsite cyclotron.                                                blood to an extent adequate for imaging. The rapidity of per-
                                                                    fusion and diffusion of this agent makes rapid imaging essen-
         POSITRON EMISSION                                          tial. Therefore, multiprobe-type cameras have predominantly
              TOMOGRAPHY                                            been employed. This tracer is not well suited to rotating cam-
                                                                    era SPECT technique. For this reason, and because of difficul-
Receptor Imaging. Neuroimaging with PET allows qualitative          ties in handling and recovering a gaseous agent, this agent has
and quantitative evaluation of receptor systems within the          largely been superseded by other radiopharmaceuticals.
brain. Adrenergic, cholinergic, dopaminergic, serotonergic,
benzodiazepine, and opioid receptors have been extensively              Iodinated amphetamines tagged with iodine 123 replaced
evaluated. PET allows true biochemical assessment of proper-        radioxenon for a time. These agents readily cross the blood
ties of these receptor systems, such as affinity, saturation and    brain barrier. Both uptake and blood brain barrier diffusion
nonspecific bindings, as well as more general information           are reversible. This agent, therefore, will slowly redistribute
about distribution and uptake kinetics. These unique capabili-      over time. Iodoamphetamine is also immediately sequestered
ties of the PET technique provide an extremely valuable             by and slowly released from the lung. This effectively yields
research tool for evaluation of brain biochemistry and devel-       slow intra-arterial injection over a period of hours. Because of
opment of both imaging agents and therapeutic pharmaceuti-          these phenomena, iodoamphetamine images represent integra-
cals. However, these studies are expensive, experimental, and       tion of all brain activity from the time of injection until com-
time consuming. Experimental uses should be clearly differen-       pletion of imaging. Because iodine-123 is cyclotron produced
tiated from proven clinical indications; the associated ethical     and has a relatively short half-life (13.2 hours), availability
issues have been assessed and summarized by the Brain               in the past has proved problematic. This agent also has been
Imaging Council of the Society of Nuclear Medicine (11).            largely superseded and is no longer commercially available in
                                                                    the United States. Agents currently in widespread use include
    Metabolic Imaging. F-18 FDG-PET is an indirect marker           Tc-99m-labeled HMPAO (exametazime/HMPAO) and ECD
of neuronal activity and allows for quantification of cerebral      (bicisate/ECD).
glucose metabolism. Clinical indications for F-18 FDG-PET
include the evaluation of epilepsy, dementia, glioma, and trau-         Tc-99m-HMPAO is an agent of the chemical microsphere
matic brain injury. PET use in epilepsy is predominantly in the     type. This agent crosses the blood brain barrier and is trapped
presurgical evaluation of partial complex seizures that fail to     within the brain substance. The mechanisms proposed for
respond to a trial of antiepileptic drugs. In mesial temporal       trapping have included change in the ionic state, binding to
lobe epilepsy, up to 85% of these patients can be cured surgi-      glutathione, and chemical decomposition (17). For purposes
cally if the focus of the abnormal brain is limited to a single     of scan interpretation, it is only necessary to understand that
temporal lobe. FDG scanning must be performed interictally          this agent essentially crosses the blood brain barrier irrevers-
in seizure patients, as the 1.83-hour half-life of F-18 does not    ibly. Unlike iodinated amphetamine, this agent provides a
allow the radiotracer to be held available for ictal scanning.      "snapshot" of brain activity for a short period after injection
Interictally, the seizure focus is usually hypometabolic. This is   (<10 minutes, with peak activity usually within 1 minute from
now thought to be due to interruptions with adjacent neurons,       IV injection). The HMPAO is available as a kit that is com-
which reduces neural activity and thus metabolism. Loss of          bined with the generator-produced, freshly eluted pertechne-
neural connections can also result in decreased metabolism in       tate before use. Availability is thus not problematic. The initial
connected and more distant sites (diaschisis). Sites of tempo-      form of this agent was unstable in aqueous solution. It had to
ral epilepsy are identified as hypometabolic foci in 70% to         be used within 30 minutes after preparation, which made qual-
85% (12) of interictal scans with a false-positive rate of only     ity control procedures difficult. A stabilized form is now avail-
5% (13). Dementia evaluation is predominantly performed             able, which can be used for 4 hours after aqueous preparation.
to separate dementia of Alzheimer type from other causes
of dementia such as frontotemporal lobe dementia, vascu-                Tc-99m-ECD is also the agent of the "chemical micro-
lar dementia, and pseudodementia due to depression. While           sphere" type (18). This agent, unlike Tc-99m-HMPAO, tends
the only unequivocal test remains brain biopsy, detection of        to not localize in areas of luxury perfusion (19) (Fig. 62.3),
Alzheimer disease (AD) with PET has a sensitivity and specific-     although there are rare exceptions (20). Although there are
ity of 78% to 83% and 78% to 94%, respectively (14), and is         a number of subtle differences between Tc-99m-ECD and
considered very reliable when applied to an appropriate popu-       HMPAO, the remaining differences are not of routine clinical
lation at risk. Patterns of activity with F-18 FDG are similar to   relevance. Tc-99m ECD is stable in aqueous solution for at
those described for SPECT agents subsequently in this review.       least 6 hours and is therefore preferable when attempting ictal
The role of PET and SPECT scanning in evaluation of brain           injection and scanning of seizure disorders due to this practical
tumors has been discussed elsewhere and will not be repeated        issue of stability. Tc-99m-HMPAO does have a slightly bet-
here. Although PET is certainly a useful technique in each of       ter extraction efficiency at higher flow rates than ECD. Both
these considerations, there are techniques available for SPECT      agents have their proponents and are in common use (21).
imaging in each of these conditions, which have similar sen-
sitivity and specificity at decreased cost (15). SPECT cameras          Technique. Brain perfusion SPECT scans are preferably
and the appropriate imaging pharmaceuticals are more likely         performed with a multidetector rotating camera. A dual head-
to occupy a continuing role in routine clinical application         rotating camera can be employed, but single head cameras are
                                                                    not generally recommended at this time. Cameras limited to
                                                                    brain work are not generally necessary due to improvements
                                                                    in equipment since the first edition of this book, although they
                                                                   Chapter 62: Central Nervous System Scintigraphy  1377

FIGURE 62.3. Ethyl Cysteinate Dimer (ECD) Versus
Hexamethylpropyleneamine Oxime (HMPAO) in
Luxury Perfusion. Transverse axial images of Tc-99m-
ECD on rows 1 and 3 and Tc-99m-HMPAO on rows
2 and 4. The photopenic defect in left frontal lobe on
ECD imaging shows uptake on HMPAO imaging.
This was a subacute stroke.

may be useful in practices with a large brain scanning referral    is mandatory throughout the scan, because patients consid-
base. High-resolution collimators should be employed (22).         ered for the study often have dementia, neurologic dysfunc-
The key issues for imaging are distance from the brain to the      tion, stroke, or another condition limiting cooperation, which
detector head and total counts acquired. One should try to         would require monitoring.
achieve the smallest possible radius of rotation camera but
remaining cognizant of patient comfort and safety.                     If sedation is required, it should be given after injection of
                                                                   the radiopharmaceutical if at all possible. Attention to medica-
    Before the procedure, the physician should review history,     tions is critical, because both presence of and withdrawal from
recorded neurologic physical examination, and a mini mental        (prescription and illicit) drugs can affect biodistribution of the
status examination if available. Historical data of importance     tracer within the brain. ECD or stabilized HMPAO should be
include symptoms and duration, history of stroke, head injury      prepared in advance if ictal scanning is to be attempted. For
or seizure, any medications (especially psychotropic anticon-      ictal scanning, the patient must be carefully and continuously
vulsants), and whether CT or MR scans have been performed.         monitored with IV catheter in place and ready availability
Neurologic examination should include cognitive and motor          of agent nearby and injected very rapidly after seizure onset,
examination and cranial nerve examination. Mental status           because generalization of seizure focus can occur very rapidly.
examination should address orientation, registration, atten-       To deploy properly, nursing staff need to perform injection
tion, recall, and language functions.                              and thus must be trained in radiation safety and proper han-
                                                                   dling of radiopharmaceuticals.
    The scanning agent is injected with a patient in a controlled
resting state. This usually involves a supine, resting patient         Acetazolamide (Diamox) is employed to assess vasodila-
with closed eyes in a quiet room (or a room with low-level         tory reserve, as it is a cerebrovascular-specific vasodilator (23).
noise) and indirect lighting (see Society of Nuclear Medicine      It should be given as a slow IV push over 5 minutes, about
procedure guidelines). Alternatively, tracer can be injected       20 minutes before radiotracer injection. The typical dosage
with seizure ictus or acute stroke. The intravenous line should    is 1000 mg for adults and 14 mg/kg for children. This agent
be established in advance and all instructions and questions       is contraindicated with known sulfa drug allergy, history of
should be dealt with before injection to avoid unintended          complicated migraine headache, or within the 3 days of acute
stimulation of brain activity. The patient should remain in        stroke. It rarely may cause postural hypotension, increasing
this controlled environment for at least 5 minutes after injec-    the need for monitoring when arising from the scanning table.
tion. A measure of 15 to 30 mCi of Tc-99m-HMPAO or Tc-             Dipyridamole and adenosine have also been used to assess vas-
99m-ECD should be employed (0.2 to 0.3 mCi/Kg in pediatric         cular reserve, but are not in routine use. All patients should
patients). A delay after injection of no less than 60 minutes      void immediately before imaging to improve comfort. This is
and preferably 90 minutes should be employed with Tc-99m-          especially important when using acetazolamide, which is a mild
HMPAO to allow for background clearance. No less than              diuretic.
10 minutes and preferably 60 minutes should elapse before
Tc-99m-ECD imaging with SPECT. Quality control on the                  Processing and Interpretation. Filtering should be per-
radiopharmaceutical should be performed before injection,          formed in all three dimensions. A low-pass filter is gener-
according to the package insert. Careful patient monitoring        ally recommended, typically a Butterworth. Other filters can
                                                                   be used, but spatially varying filters may create artifacts,
1378  Section Twelve: Nuclear Radiology

A                                                                  B

FIGURE 62.4. Normal Hexamethylpropyleneamine Oxime (HMPAO) Study. Selected images from a normal Tc-99m-HMPAO study. A. Axial
images. B. Representative central images in three standard planes (axial, sagittal, and coronal to long axis of brain). Large arrow indicates the
brainstem; small arrow indicates the basal ganglia. With modern equipment, it should be possible to routinely obtain scans that resolve gyri, basal
ganglia, and brainstem. Interpreters should consult an atlas to familiarize themselves with the normal distribution of radiotracer in the brain
structures.

particularly in low-count studies. The whole brain should             of Nuclear Medicine at the time this chapter was written.
be reconstructed, taking care to include the vertex and the           Readers are encouraged to check the current guidelines before
cerebellum. Any summing of data should occur only after               initiating a brain imaging program (www.snm.org).
reconstruction at single-pixel slices. Attenuation correction
should always be performed in patients with intact skulls and             Indications. According to the American Academy of Neu-
data should be evaluated in three orthogonal planes. It is also       rology, the established indications for these techniques are
important to evaluate the raw data for acquisition errors.            confirmation of Alzheimer's disease, presurgical ictal identifi-
These should be evaluated on rotating display to check for            cation of seizure foci, and evaluation of acute brain ischemia
patient motion during acquisition, which can also create              (25). Most nuclear medicine physicians in clinical practice
serious artifacts. Rigorous quality control is required for all       would consider brain death evaluation to be an established
these as well as other SPECT studies. Averaged slices should          indication for planar brain scans. Areas considered promising
approach the Full-Width Half Maximum of the device. It is             by the American Academy of Neurology are determination of
worthwhile to reconstruct the transaxial plane images along           stroke subtypes, assessment of vasospasm following subarach-
the anterior to posterior commissural line. A typical normal          noid hemorrhage, and (nonictal) localization of seizure foci.
study is demonstrated in Figure 62.4.                                 Therapeutic options for these disorders including medical or
                                                                      interventional are available. The expansion of research into
    In interpretation, it is important that background subtrac-       use of brain SPECT in psychiatric disorders, where therapeutic
tion not be excessive and that a continuous color scale (or a         options are broad but objective evaluation of biologic aspects
continuous gray scale) be employed to avoid artifactual edges.        of the diseases is extremely weak, is promising but as yet not
The range of normal should be considered in rendering an              validated (26). The remainder of the discussion will be limited
opinion and one should use a normal database specific to the          primarily to the accepted indications, with brief discussion of
radiopharmaceutical that is employed. Correlation with clini-         other applications considered promising, applications to pre-
cal data is required. Any regional perfusion defects should also      surgical planning (balloon occlusion test and Wada test) and
be correlated with the locations of any CT or MR abnormali-           testing of vascular reserve.
ties. This is substantially easier if some type of fusion imaging
(overlay of anatomic and functional images with or without                Applications for brain SPECT include the following:
the use of fiduciary markers) (24) is employed, but can be                Stroke and Ischemia. The extent of stroke can be deter-
performed visually. Extent and severity of defects should be          mined a short time after its occurrence with functional brain
reported. Statistical mapping software is also available that         scanning (Figs. 62.5, 62.6). 99m-Tc ECD demonstrated a
allows for comparison to a healthy control group. Voxel-based         specificity of 98% and sensitivity of 86% for localization of
mapping details quantitative differences on a 3D brain map            acute strokes (27). This contrasts with several hours for stan-
that helps to localize variations in expected cerebral perfusion.     dard MR (28) and CT (29). Molecular diffusion imaging, with
(For those who are interested in NEUROSTAT and 3D-SSP,                MRI, has allowed improved assessment of strokes acutely (30).
please visit http://128.95.65.28/Download/.)                          Therapeutic administration of tissue plasminogen activator is
                                                                      effective, but the time between initial onset and therapy is criti-
    The recommendations for image acquisition, processing,            cal. The time of onset must be established and hemorrhagic
and interpretation conform generally and specifically to the          stroke excluded before administration of tissue plasminogen
recommendations of the Brain Imaging Council of the Society           activator. CT is employed to rapidly exclude hemorrhage, and
                                                              Chapter 62: Central Nervous System Scintigraphy  1379

FIGURE 62.5. Cerebral Infarction. Transaxial images
reformatted into the plane of the orbitomeatal line
(standard CT format) from a I-123-iofetamine scan
show a large region of absent perfusion (arrows) in
the distribution of the left middle cerebral artery after
cerebral infarction. Note the decreased cerebellar
activity on the side opposite the infarct (arrow), an
example of crossed cerebellar diaschisis. This phe-
nomenon results from decreased right cerebellar
metabolism due to decreased neuronal communica-
tion between the right cerebellum and the infarcted
portion of the left cerebral hemisphere. (All iofetamine
images in this chapter were obtained during phase III
trials of the agent under approved protocol. Modern
equipment allows significant improvement in resolu-
tion.)

administration is begun as soon thereafter as possible (31).  agulation requires only exclusion of hemorrhage, which is best
Functional imaging has not been widely employed on the the-   accomplished with CT.
ory that it would delay therapy when stroke has already been
confirmed clinically. Therapy of acute stroke has otherwise       The use of functional imaging to evaluate for ischemia due
been limited to anticoagulation and supportive care. Antico-  to vasospasm after subarachnoid hemorrhage is supported by
                                                              ACR Practice Guidelines for brain perfusion SPECT (2007)

FIGURE 62.6. Subcortical Cerebral Infarct. Transverse
axial images of Tc-99m-ethyl cysteinate dimer in patient
with acute stroke shows absence of uptake in the left
lenticular nucleus (arrow).
1380     Section Twelve: Nuclear Radiology

         A

      B                                                          C

      FIGURE 62.7. Subarachnoid Hemorrhage and Cerebral Vasospasm. A. Transverse axial images of Tc-99m-ethyl cystein-
      ate dimer show baseline scan on rows 2 and 4 and scan during vasospasm on rows 1 and 3. New defect is seen in left
      hemisphere in posterior frontoparietal cortex corresponding to ischemia from vasospasm. B. Left internal carotid angio-
      gram shows vasospasm in midportion of left middle cerebral artery. C. Later angiogram of left internal carotid artery
      shows resolution of vasospasm after percutaneous transluminal microballoon angioplasty.

(http://www.acr.org/SecondaryMainMenuCategories/quality_         identifying a lacunar stroke (36). High-resolution SPECT has
safety/guidelines/nuc_med.aspx). Vasospasm of clinical impact    the potential to image lacunar strokes as well. Early differentia-
occurs in 30% of patients with subarachnoid hemorrhage           tion of mechanism is important, because embolic disease should
(Fig. 62.7) (32). SPECT brain imaging in association with neu-   prompt cardiac evaluation for a source and consideration of
rologic examination and transcranial Doppler (TCD) artery        anticoagulant therapy. Prediction of prognosis after stroke or
narrowing assessment allows effective noninvasive monitoring     TIA is another area of likely application. Lesion volume cor-
and early intervention (33,34). As there are multiple poten-     relates with early outcome in acute stroke, and large, severe
tial therapies (hyperdynamic hypertension, hemodilution and      perfusion defects are predictive of nonnutritive perfusion (37).
hypovolemia, calcium channel blockers, micro-balloon cere-       After transient ischemic attack (TIA), a prolonged deficit on
bral angioplasty, and intra-arterial papaverine) that require    functional scanning with brain SPECT predicts high likelihood
definitive diagnosis, this technique has clinical use. A recent  of ischemic stroke in the period following the TIA (38).
publication showed similar sensitivity and specificity of SPECT
and TCD in vasospasm (35).                                           In the early phase of cerebrovascular compromise, blood
                                                                 flow is maintained through autoregulated vasodilatation,
    In patients with ischemic stroke, a nearly normal brain      leading to an increase in blood volume. As the compensa-
SPECT study may be an indication of lacunar infarction. Using    tory capacity of autoregulation is exceeded, blood flow falls,
this criterion, SPECT was 69% sensitive and 100% specific in     while oxygen metabolism is maintained, corresponding to an
                                                                  Chapter 62: Central Nervous System Scintigraphy  1381

FIGURE 62.8. Acetazolamide Vascular Reserve
Testing in Occlusive Carotid Disease. Transverse axial
images of Tc-99m-ethyl cysteinate dimer with acetazol-
amide on rows 1 and 3 and at rest on rows 2 and 4.
Images show decreased uptake in left hemisphere with
acetazolamide that improves largely at rest. This find-
ing indicates exhausted vasodilatory reserve in left
hemisphere corresponding to left internal carotid artery
occlusion.

increase in oxygen extraction fraction (the beginning of mis-         Injection during vascular occlusion of a carotid artery can
ery perfusion). Once oxygen extraction fraction has increased     test cross-circulation across the circle of Willis, demonstrating
maximally, continued decline in blood flow leads to a decline     the precise areas of decreased perfusion during occlusion. This
in oxygen delivery and metabolism (the onset of ischemia).        is the nuclear medicine version of the Matas test (40 - 42) (Fig.
Severe and prolonged compromise results in infarction of          62.9). The distribution of amobarbital injected for localization
brain tissue, with decreased demand for oxygen metabolism,        of speech and memory functions (the Wada test) may also be
while vasodilatation persists, leading to a decline in oxygen     assessed accurately using functional agents as tracers (43).
extraction fraction (and onset of "luxury perfusion"). As
revascularization occurs, blood flow to the region increases          Dementia. The most important use for PET imaging in the
and the infarcted area typically remains in a state of luxury     workup of the dementia patient is to aid in making an accurate
perfusion for days to weeks.                                      diagnosis as early in the course of Alzheimer's disease as pos-
                                                                  sible, and, in a review by Silverman, F-18 FDG-PET appears to
    By judicious use of acetazolamide to test vasodilatory        supersede SPECT in this area (44). It can be diagnosed with an
reserve of the cerebral vessels, it is possible to perform the    accuracy of approximately 80% with functional SPECT brain
equivalent of pharmacologic coronary stress imaging for           scans (45). In patients with AD of varying severity, the magni-
cerebral vessels. Studies with and without acetazolamide          tude and extent of hypometabolism correlates with the sever-
may provide information on the mechanism of ischemia              ity of the dementia symptoms. The earliest findings in AD on
(39). These studies may also be useful in presurgical plan-       FDG-PET is hypometabolism of the posterior cingulate cortex
ning when carotid surgery or intracranial/extracranial bypass     (46), which also seems to be a distinguishing feature between
surgery is contemplated because they can indicate the physi-      frontotemporal dementia and Alzheimer's disease cited in work
ologic significance of an anatomic vascular lesion. Interpreta-   using SPECT (47). Usually, there are only minor decreases in
tion of these studies depends on identification of a significant  the parietal lobes in patients with early mild AD. Moderately
area of relatively decreased perfusion (actually indicating       affected patients show significantly decreased metabolism in
increased perfusion in the unaffected portions of the brain)      the bilateral parietal lobes and the temporal regions. In patients
after stimulation, which was not present in the study with-       with severe Alzheimer's disease, the same regions are affected,
out stimulation, which would indicate impaired vasodilatory       but the hypometabolism is much more pronounced with spar-
reserve (Fig. 62.8). This is exactly analogous to evaluation of   ing only of the sensorimotor, visual, and subcortical areas. The
coronary artery reserve with dipyridamole or adenosine stress     typical pattern is decreased activity in parietal and posterior
imaging as discussed elsewhere. Ramsay et al. (23) showed         temporal regions bilaterally but often asymmetrically. (Fig.
that the combination of acetazolamide and cerebral Tc-99m-        62.10) The characteristic Alzheimer's disease radiotracer dis-
HMPAO was used to demonstrate reduction in cerebral blood         tribution pattern is similar for SPECT and PET imaging. The
flow reserve, which improved after carotid endarterectomy         classic bitemporoparietal defect of Alzheimer's can also be seen
in 45% of selected patients with unilateral internal carotid      in other conditions including carbon monoxide poisoning,
artery stenosis.                                                  hypoglycemia, mitochondrial encephalomyelopathy, severe
                                                                  Parkinson disease, and diffuse Lewy body dementia, although
    As with coronary studies, evaluation of clinical data, accu-  diffuse Lewy body dementia often involves hypometabolism of
rate registration of images, and comparison to a radiopharma-     the visual cortex as well.
ceutical specific normal database are important.
1382  Section Twelve: Nuclear Radiology

A                                        B

                                            FIGURE 62.9. Positive Balloon

                                            Occlusion Study. A, B. This patient

                                            was asymptomatic after inflation of

                                            the left carotid artery balloon, but

                                            images show decreased regional blood

                                            flow in the left middle cerebral artery

                                            distribution (arrow). C, D. Baseline

                                            study shows normal tracer distribu-

                                            tion. If occlusion study had been nor-

                                            mal, the baseline images would be

                                            omitted. Radiopharmaceutical is

                                            T c-99m-hexamethylpropyleneamine

C                                        D  oxime.

                                            FIGURE 62.10. PET in Alzheimer Disease.
                                            Transaxial plane from FDG-PET scan in
                                            Alzheimer disease. Note preservation of
                                            metabolism in sensorimotor cortex, visual
                                            cortex, basal ganglia, thalami, and cerebel-
                                            lum. Note deficit of metabolic activity in
                                            temporoparietal association cortex bilater-
                                            ally. (Image courtesy of Satoshi Minoshima,
                                            MD, PhD.)
                                                                   Chapter 62: Central Nervous System Scintigraphy  1383

FIGURE 62.11. Three-dimensional SSP Display of SPECT in Alzheimer Disease. Stereotactic three-dimensional surface projection display of
Z-scores in brain SPECT in Alzheimer disease showing statistically significant decreases in perfusion in bilateral temporoparietal association cor-
tices and also in posterior cingulate. GLB, THL, CBL, and PNS indicate that each corresponding row is normalized to global, thalamic, cerebel-
lar, and pons uptake, respectively.

    Frontotemporal lobe degeneration (including the subtype            Diffuse Lewy body dementia, which is characterized by
Pick disease, which is associated with cognitive and language      visual hallucination, fluctuating cognitive decline, and Parkin-
dysfunction and behavioral changes) can generally be differen-     sonian symptoms, has been reported to be the second most
tiated from Alzheimer's disease. Frontotemporal lobe degen-        common type of degenerative dementia, accounting for up to
eration is classically associated with frontotemporal perfusion    20% of all dementia cases at autopsy. SPECT findings include
defects on brain SPECT (48). Again, the pattern is not specific    temporoparietal hypoperfusion similar to Alzheimer's disease
to this group of diseases (depression, alcoholism, schizophre-     and occipital lobe hypoperfusion. Occipital hypometabolism
nia, Pick disease, severe Alzheimer's disease, and progressive     (or hypoperfusion) measured by PET and SPECT yielded dif-
supranuclear palsy forms the differential). Vascular dementias     ferential diagnostic accuracy of probable diffuse Lewy body
can result in defects in any portion of the brain and can coexist  dementia from probable Alzheimer disease with sensitivity
with Alzheimer's disease in a proportion of the elderly. Further   and specificity of 92%. Similarly, hypometabolism in the pri-
complicating the picture is an increasing tendency for nonspe-     mary visual cortex differentiated probable diffuse Lewy body
cific defects to occur in older patients, especially as a result   dementia from probable Alzheimer disease with 86% sensitiv-
of sulcal enlargement due to brain atrophy. The evaluation of      ity and 91% specificity. An MRI study indicated that absence
dementia is, therefore, not a simple task and should require       of medial temporal atrophy could separate diffuse Lewy body
anatomic as well as functional imaging, and it is recommended      dementias from Alzheimer disease or vascular dementia with
that quantitative analysis software be employed for corrobo-       specificity of 100% and 88% respectively, but sensitivity was
ration. Use of quantitative software techniques (Fig. 62.11)       only 38% (52).
have aided the visual interpretation and accuracy of dement-
ing diseases (49,50) and have helped to identify hypoperfusion         Vascular disease contributing to dementia, which is poten-
or hypometabolism of posterior cingulate gyrus and parietal        tially reversible, can be unmasked by administration of acet-
precuneus as the earliest findings in Alzheimer's disease.         azolamide with SPECT and compared against anatomic
                                                                   imaging suggesting vascular disease. In multi-infarct demen-
    A negative PET scan indicated that pathologic progression      tia, patients typically present abruptly with a history of prior
of cognitive impairment during the mean 3-year follow-up           stroke and hypertension. Generally speaking, there are mul-
was unlikely to occur (51). There is substantial clinical over-    tiple perfusion deficits evident that may be equivalent or more
lap between elderly patients with Alzheimer's disease, vascular    extensive than the findings on MR scan. The likelihood of
dementia, and pseudodementia due to depression. Thus, hav-         development of etiologically specific therapies for at least some
ing scans that can help in the differential diagnosis is quite     dementias remains high, making continued investigation of
important. The therapeutic options (such as cholinesterase         diagnostic techniques of utmost importance. Follow-up scans
inhibitors and glutamate regulators) for treating Alzheimer's      improve sensitivity and specificity by demonstrating an appro-
disease symptoms have been slowly emerging and have had            priate pattern of progression in true dementias.
some clinical benefits in the past decade. As yet, there are no
disease-altering therapeutics.                                         Seizure Disorder. Temporal lobe syndrome with typi-
                                                                   cal complex partial seizures is typically evaluated with
1384  Section Twelve: Nuclear Radiology

                                                                     FIGURE 62.12. Ictal and Interictal SPECT Scans in
                                                                     Complex Partial Epilepsy. Transverse axial images of
                                                                     Tc-99m-ethyl cysteinate dimer injected with seizure
                                                                     ictus on rows 1 and 3 and also injected during interic-
                                                                     tal time period on rows 2 and 4. Ictal imaging shows
                                                                     increased uptake in right hemisphere, which is pre-
                                                                     dominantly in right temporal lobe. Interictal imaging
                                                                     shows relatively decreased uptake in right temporal
                                                                     lobe.

electroencephalography (EEG), MRI, and continuous video              on the side chosen for resection in most cases (sensitivity, 71%;
monitoring. Routine ictal and interictal SPECT in these              specificity, 100%) and was predictive of favorable postsurgical
patients may not add significant diagnostic help, and patients       outcome in 90% of the patients (56).
are typically offered temporal lobectomy without SPECT when
the clinical syndrome is concordant with findings on EEG and             The findings from some studies have suggested that met-
MRI. The seizure disorder most commonly referred for medi-           abolic dysfunction of the thalamus ipsilateral to the seizure
cal imaging is the patient with a temporal lobe syndrome, typ-       focus becomes more severe with long-standing temporal or
ically complex partial seizures. Interictally, seizure foci tend to  frontal lobe epilepsy and also with secondary generalization
have decreased activity and increased activity with ictus (Fig.      of seizures.
62.12). In simplistic terms, focal neuronal loss or damage
results in a local phenomenon similar to diaschisis. Because of          FDG-PET is also a sensitive and specific technique for
secondary activation and spread of the seizure foci, it is dif-      investigating patients with seizures of probable frontal lobe
ficult to pinpoint the exact seizure focus unless injection can      origins, because many of these seizures begin in the medial or
be made early during the seizure. This should be confirmed by        inferior aspects of the frontal lobe, and scalp EEG readings
video/EEG review. However, ictal SPECT may identify seizure          do not provide adequate localization of foci. Performing ictal
foci, which are not identified by MR, and is especially useful       PET studies is logistically impractical primarily because of the
in epileptogenic cortical developmental disorders (53) where         relatively short half-life of the positron-emitting isotopes, such
EEG often fails to find the epileptogenic focus (54). An ictal       as F-18 or 15O. Receptor PET imaging with 11C-flumazenil
SPECT study showing an area of increased regional blood              (FMZ), although still investigational, may have a useful clini-
flow, which may correspond to an area of decreased regional          cal role in patients with partial epilepsy who have normal or
blood flow on interictal SPECT, is strong evidence for an epi-       nondiagnostic FDG-PET, in patients with bilateral FDG find-
leptogenic lesion. Ictal SPECT is reported to be more accurate       ings but unifocal seizure activity on EEG, and in patients after
than interictal SPECT and PET with overall accuracy rates            surgical resection who continue to have seizures (57). Excision
greater than 90% (55). In the group with structural lesions,         of well-localized foci on C-11 FMZ-PET can lead to elimina-
the two techniques had comparable results. Both ictal SPECT          tion of seizures or significantly improve pharmacological con-
and interictal PET have complimentary roles where localiza-          trol in 80% of surgical patients.
tion is difficult. If these findings also concur with the EEG
findings or CT/MR evidence of a lesion, the need for more                Viral encephalopathies can present a diagnostic imaging
invasive depth electrocorticography or intraoperative electro-       challenge. Launes et al. (58) reported abnormal increased
corticography may be obviated or more accurately guided.             accumulation of Tc-99n-HMPAO in the affected temporal
For this indication, the technique will be applied mainly in         lobe even at an early stage of herpes simplex encephalopathy
larger referral centers that perform surgery for removal of the      when CT was normal.
seizure foci.
                                                                         Brain Tumors. PET can play an important role in the
    When newer methods for analyzing PET images such as              evaluation and management of patients with brain tumors,
statistical parametric mapping were used to detect temporal          including the grading of tumors, determining of prognosis,
interhemispheric asymmetry, hypometabolism was identified            and the differentiation of recurrent tumor from radiation
                                                                     necrosis (59). The sensitivity for making the determination
                                                                     of radiation necrosis versus tumor recurrence may be as
                                                                     high as 86% with specificity as high as 56%. FDG studies
                                                                  Chapter 62: Central Nervous System Scintigraphy  1385

FIGURE 62.13. I-123 Ioflupane (FP-CIT) SPECT.
I-123 ioflupane SPECT images at level of basal ganglia
over time in a patient with Parkinson disease show
progressive decline in uptake, reflecting loss of dopa-
minergic function.

have concluded that high-grade tumors are hypermetabolic,         to bind with high affinity to dopamine transporter (65). Cur-
whereas low-grade tumors can be hypometabolic. One dis-           rently, [123I] -CIT ([123I]2-carboxymethoxy-3-4-iodophenyl
tinction from this typology is juvenile pilocytic astrocytomas,   tropane) (DOPASCAN) and [123I]FP-CIT (fluoropropyl-2-
which typically have a high-glucose metabolism despite their      carbomethoxy-3-4-iodophenyl nortropane) (DaTSCAN) are
benign nature. It should be noted that PET may not dif-           commercially available in Europe and are imminently to be
ferentiate between primary lymphomas of the CNS, brain            available in the United States. Before receiving the radiotracer,
metastases, or malignant gliomas because all of these may be      the thyroid should be blocked with an appropriate dose of
hypermetabolic.                                                   sodium perchlorate (at least 200 mg 60 minutes before injec-
                                                                  tion). The radiopharmaceutical is injected slowly over 20 min-
    Brain Trauma. SPECT brain imaging has been proposed           utes. With DOPASCAN, the patient is imaged 18 to 24 hours
to confirm the presence of a focal or diffuse injury in patients  later, and with DaTSCAN, images are acquired after 3 to
with persistent symptoms after trauma but normal or nondiag-      6 hours (66).
nostic anatomic imaging studies (60). The increased sensitivity
of functional SPECT relative to CT or MR favors this use and          Indications. [123I]FP-CIT imaging is indicated for detect-
is supported by ACR Practice Guidelines on brain perfusion        ing loss of functional dopaminergic neuron terminals in the
SPECT (2007). In addition, recent studies in mild traumatic       striatum of patients with clinically uncertain Parkinsonian
brain injury patients have shown important abnormalities in       syndromes. It helps differentiate essential tremor from Par-
cerebellar function and its relationship to the cerebral cortex   kinsonian syndromes related to Parkinson's disease, multiple
with both SPECT and PET studies (61,62).                          system atrophy, and progressive supranuclear palsy. On its
                                                                  own, [123I]FP-CIT imaging is unable to discriminate between
    Parkinson disease is a clinical diagnosis based on classic    PD, multiple system atrophy, and supranuclear palsy. These
motor dysfunction including bradykinesia, rigidity, and rest      conditions may be better assessed by D2 receptor radioli-
tremor. The main neuropathologic feature is a severe degen-       gands.
eration of the dopaminergic neurons in the substantia nigra
resulting in loss of dopamine transporters in the striatum (63).      Interpretation. Visual assessment of the striatum, including
In 10% to 20% of cases, there is ambiguity in the clinical        the caudate and putamen, can be aided by fusion techniques
diagnosis, and additional testing can improve diagnostic accu-    with the patient's own brain MRI or with a normal database.
racy (64). The primary focus of diagnosis with neuroimaging       Semiquantitative analysis with range-of-interest (ROI) analy-
is demonstration of degeneration of dopaminergic neurons          sis using transaxial images with the highest striatal binding or
in the substantia nigra with dopamine transporter ligands.        the entire striatal volume is taken into account. Comparison
Dopamine transporter is a presynaptic dopamine symporter          to normal age-matched controls of the entire striatum, head of
responsible for presynaptic dopamine reuptake. Identification     the caudate, and putamen is assessed.
of decreased dopamine transporter in the striatum has proven
to be a selective and reliable measure in the diagnosis of            The report should include if a presynaptic dopaminergic
Parkinson's disease (Fig. 62.13).                                 deficit has been confirmed or excluded by the study. The extent
                                                                  and characteristics (e.g., asymmetry, predominantly affected
    Radiopharmaceutical and Technique. Various cocaine            structures) of an observed presynaptic dopaminergic deficit
analogues labeled with 123I suitable for SPECT have shown         should be recorded.
1386  Section Twelve: Nuclear Radiology

                      References                                                  30. LeBihan D. Molecular diffusion nuclear magnetic resonance imaging.
                                                                                       Magn Reson Q 1991;7:1-30.
 1. Idea RJ, Lewis DH. Timely diagnosis of brain death in an emergency
     trauma center. AJR Am J Roentgenol 1994;163:927-928.                         31. Tissue plasminogen activator for acute ischemic stroke. The National
                                                                                       Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.
 2. Mrhac L, Zakko S, Parikh Y. Brain death: the evaluation of semi-quanti-            N Engl J Med 1995;33:1581-1587.
     tative parameters and other signs in HMPAO scintigraphy. Nucl Med
     Commun 1995;16:1016-1020.                                                    32. Soucy JP, McNamara D, Mohr G, et al. Evaluation of vasospasm second-
                                                                                       ary to subarachnoid hemorrhage with Technetium-99m-hexamethyl-pro-
 3. Laurin NR, Driedger AA, et al. Cerebral perfusion imaging with techni-             pyleneamine oxime (HM-PAO) tomoscintigraphy. J Nucl Med 1990;
     tium-99mHMPAO in brain death and severe central nervous system                    31:972-997.
     injury. J Nucl Med 1989;30:1627-1635.
                                                                                  33. Davis SM, Andrews JT, Lichtenstein M, et al. Correlations between cere-
 4. Reid RH, Gulenchyn K, Ballinger JR. Clinical use of technetium-99m                 bral arterial velocities, blood flow, and delayed ischemia after subarach-
     HMPAO for determination of brain death. J Nucl Med 1989;30:1621-                  noid hemorrhage. Stroke 1992;23:492-497.
     1626.
                                                                                  34. Lewis DH, Hsu S, Eskridge J, et al. Brain SPECT and transcranial Doppler
 5. Harbert JC. Radionuclide cisternography. Semin Nucl Med 1971;1:90-                 ultrasound in vasospasm-induced delayed cerebral ischemia after sub-
     106                                                                               arachnoid hemorrhage. J Stroke Cerebrovasc Dis 1992;2:12-21.

 6. Hughes CP, Siegel BA, Coxe WS, et al. Adult idiopathic communicating          35. Cooke D, Koppula B, Seiler D, et al. Semiquantitative software SPECT
     hydrocephalus with and without shunting. J Neurol Neurosurg Psychiatry            analysis in aneurysmal subarachnoid hemorrhage-related vasospasm.
     1978;41:961-971.                                                                  Nucl Med Commun 2010;31:53-58.

 7. McKusick KA, Malmud LS, Kordela A, Wagner HN Jr. Radionuclide cis-            36. Alexandrov AV, Black SE, Ehrlich LE, et al. Simple visual analysis of brain
     ternography: normal values for nasal secretion of intrathecally injected          perfusion on HMPAO SPECT predicts early outcome in acute stroke.
     111-In-DTPA. J Nucl Med 1973;14:933-934.                                          Stroke 1996;27:1537-1542.

 8. Di Chiro G, Ommaya AK, Ashburn WL, Briner WH. Isotope cisternogra-            37. Infield B, Davis SM, Donnan GA, et al. Streptokinase increases luxury
     phy in the diagnosis and follow up of cerebrospinal fluid rhinorrhea.             perfusion after stroke. Stroke 1996;27:1524-1529.
     J Neurosurg 1968;28:522-529.
                                                                                  38. Bogousslavsky J, Delaloye-Bischof A, Regli F, Delaloye B. Prolonged
 9. Rudd TG, Shurtleff DB, Loeser JD, Nelp WB. Radionuclide assessment of              hypoperfusion and early stroke after transient ischemic attack. Stroke
     cerebrospinal fluid shunt function in children. J Nucl Med 1973;14:683-           1990;21:40-46.
     686.
                                                                                  39. Chollet F, Celsis P, Clanet M, et al. SPECT study of cerebral blood flow
10. O'Brien DF, Taylor W, Park TS, Ojemann. A critical analysis of `normal'            reactivity after acetazolamide in patients with transient ischemic attacks.
     radionucleotide shuntograms in patients subsequently requiring surgery.           Stroke 1989;20:458-464.
     Childs Nerv Syst 2003;19:337-341.
                                                                                  40. Matsuda H, Higashi S, Asli IN, et al. Evaluation of cerebral collateral cir-
11. Society of Nuclear Medicine Brain Imaging Council. Ethical clinical prac-          culation by technetium-99m HMPAO brain SPECT during Matas test:
     tice of functional brain imaging. J Nucl Med 1996;37:1256-1259.                   report of three cases. J Nucl Med 1988;29:1724-1729.

12. la Fougere C, Rominger A, Frster S, et al. PET and SPECT in epilepsy: a      41. Monsein LH, Jeffery PJ, van Heerden BB, et al. Assessing adequacy of col-
     critical review. Epilepsy Behav 2009;15:50-55.                                    lateral circulation during balloon test occlusion of the internal carotid
                                                                                       artery with 99mT c HMPAO SPECT. AJNR Am J Neuroradiol 1991;
13. Messa C, Fazio F, Costa DC, Ell PJ. Clinical brain radionuclide imaging            12:1045-1051.
     studies. Semin Nucl Med 1995;15:111.
                                                                                  42. Peterman SB, Taylor A Jr, Hoffman JC Jr. Improved detection of cerebral
14. Haense C, Herholz K, Jagust WJ, Heiss WD. Performance of FDG PET                   hypoperfusion with internal carotid balloon occlusion and 99mTc-
     for detection of Alzheimer's disease in two independent multicenter sam-          HMPAO cerebral perfusion SPECT imaging. AJNR Am J Neuroradiol
     ples (NEST-DD and ADNI). Dement Geriatr Cogn Disord 2009;28:259-                  1991;12:1035-1041.
     266.
                                                                                  43. Jeffery PJ, Monsein LH, Szabo Z, et al. Mapping the distribution of amo-
15. Borghesani PR, DeMers SM, Manchanda V, et al. Neuroimaging in the                  barbital sodium in the intracarotid Wada test by use of Tc-99m HMPAO
     clinical diagnosis of dementia: observations from a memory disorders              with SPECT. Radiology 1991;178:847-850.
     clinic. J Am Geriatr Soc 2010;58:1453-1458.
                                                                                  44. Silverman DH. Brain 18F-FDG PET in the diagnosis of neurodegenerative
16. Hartshorne ME. Positron emission tomography. In: Orrison WW, Lewine                dementias: comparison with perfusion SPECT and with clinical evalua-
     JD, Sanders JA, Hartshorne MF, eds. Functional Brain Imaging. St. Louis,          tions lacking nuclear imaging. J Nucl Med 2004;45:594-607.
     MO: Mosby, 1995:187-212.
                                                                                  45. Holman BL, Johnson KA, Gerada B, et al. The scintigraphic appearance of
17. Suess E, Malessa S, Ungersbock K, et al. Technetium-99m-d,l-                       Alzheimer's disease: a prospective study using technetium-99m-HMPAO
     hexamethylpropyleneamine oxime (HMPAO) uptake and glutathione                     SPECT. J Nucl Med 1992;33:181-185.
     content in brain tumors. J Nucl Med 1991;32:1675-1681.
                                                                                  46. Minoshima S, Foster NL, Kuhl DE. Posterior cingulate cortex in
18. Leveille J, Demonceau G, Walovitch RC. Intrasubject comparison between             Alzheimer's disease. Lancet 1994;344:895.
     technetium-99m-ECD and technetium-99m-HMPAO in healthy human
     subjects. J Nucl Med 1992;33:480-484.                                        47. Lipton AM, Benavides R, Hynan LS, et al. Lateralization on neuroimaging
                                                                                       does not differentiate frontotemporal lobar degeneration from Alzheimer's
19. Shisido F, Uemura K, Inugami A, et al. Discrepant 99mTc-ECD images of              disease. Dement Geriatr Cogn Disord 2004;17:324-327.
     CBF in patients with subacute cerebral infarction: a comparison of CBF,
     CMRO2and 99mTc-HMPAO imaging. Ann Nucl Med 1995;9:161-169.                   48. Clinical and neuropathological criteria for frontotemporal dementia. The
                                                                                       Lund and Manchester Groups. J Neurol Neurosurg Psychiatry
20. Krishnanathan R, Minoshima S, Lewis D. Tc-99m ECD neuro-SPECT                      1994;57:416-418.
     and diffusion weighted MRI in the detection of the anatomical extent of
     subacute stroke: a cautionary note regarding reperfusion hyperemia. Clin     49. Bonte FJ, Harris TS, Roney CA, Hynan LS. Differential diagnosis between
     Nucl Med 2007;32:700-702.                                                         Alzheimer's and frontotemporal disease by posterior cingulate sign. J Nucl
                                                                                       Med 2004;45:771-774.
21. Moretti JL, Caglar M, Weinmann P. Cerebral perfusion imaging tracers
     for SPECT: which one to choose? J Nucl Med 1995;36:359-363.                  50. Minoshima S, Foster NL, Kuhl DE. Posterior cingulate cortex in
                                                                                       Alzheimer's disease. Lancet 1994;344:895.
22. Kim HJ, Karp JS, Mozley PD, et al. Simulating technetium-99m cerebral
     perfusion studies with a three-dimensional Hoffman brain phantom: col-       51. Silverman DH, Small GW, Chang CY, et al. Positron emission tomography
     limator and filter selection in SPECT neuroimaging. Ann Nucl Med                  in evaluation of dementia. Regional brain metabolism and long-term out-
     1996;10:153-160.                                                                  come. JAMA 2001;286:2120-2127.

23. Ramsay, SC, Yeates MG, Lord RS, et al. Use of technetium-HMPAO to             52. Minoshima S, Foster NL, Sima AA, et al. Alzheimer's disease versus
     demonstrate changes in cerebral blood flow reserve following carotid end-         dementia with Lewy bodies: cerebral metabolic distinction with autopsy
     arterectomy. J Nucl Med 1991;32:1382-1386.                                        confirmation. Ann Neurol 2001;50:358-365.

24. Pietrzyk U, Herholz K, Schuster A, et al. Clinical applications of registra-  53. Kuzniecky R, Mountz J, Wheatly G, Morawetz R. Ictal single-photon
     tion and fusion of multimodality brain images from PET, SPECT, CT, and            emission computed tomography demonstrates localized epileptogenesis in
     MRI. Eur J Radiol 1996;21:174-182.                                                cortical dysplasia. Ann Neurol 1993;34:627-631.

25. Assessment of brain SPECT: report of the therapeutics and Technology          54. Palmini A, Andermann F, Olivier A, et al. Focal neuronal migration disorders
     Assessment Subcommittee of the American Academy of Neurology.                     and intractable partial epilepsy: a study of 30 patients. Ann Neurol 1991;
     Neurology 1996;46:278-285.                                                        30:741-749.

26. O'Connell RA. Psychiatric disorders. In: Van Heertum RL, Tikofsky RS,         55. Ho SS, Berkovic SF, Berlangieri SU, et al. Comparison of Ictal SPECT and
     eds. Cerebral SPECT Imaging. 2nd ed. New York: Raven Press, 1995.                 interictal PET in the presurgical evaluation of temporal lobe epilepsy. Ann
                                                                                       Neurol 1995;37:738-745.
27. Brass LM, Walovitch RC, Joseph JL, et al. The role of single photon emis-
     sion computed tomography brain imaging with 99m Tc bicisate in the           56. Drzezga A, Arnold S, Minoshima S, et al. F-18 FDG PET studies in
     localization and definition of mechanism of ischemic stroke. J Cereb              patients with extratemporal and temporal epilepsy: evaluation of an
     Blood Flow Metab 1994;14(Suppl 1):S91-S98.                                        observer-independent analysis. J Nucl Med 1999;40:737-746.

28. Alberts MJ, Faulstich ME, Gray L. Stroke with negative brain magnetic         57. Hammers A, Koepp MJ, Labbe C, et al. Neocortical abnormalities of
     resonance imaging. Stroke 1992;23:663-667.                                        [11C] flumazenil PET in mesial temporal lobe epilepsy. Neurology
                                                                                       2001;56:897-906.
29. Bose A, Pacia SV, Fayad P, et al. Cerebral blood flow (CBF) imaging com-
     pared to CT during the initial 24 hours of cerebral infarction. Neurology    58. Launes J, Nikkinen P, Lindroth L, et al. Diagnosis of acute herpes simplex
     1990;40:190.                                                                      encephalitis by brain perfusion single photon emission computed tomog-
                                                                                       raphy. Lancet 1988;1:1188-1191.
                                                                                  Chapter 62: Central Nervous System Scintigraphy  1387

59. Hustinx R, Pourdehnad M, Kaschten B, Alavi A. PET imaging for differ-         63. Booij J, Tissingh G, Boer GJ, et al. [123I]FP-CIT SPECT shows a pro-
     entiating recurrent brain tumor from radiation necrosis. Radiol Clin              nounced decline of striatal dopamine transporter labeling in early and
     North Am 2005;43:35-47.                                                           advanced Parkinson's disease. J Neurol Neurosurg Psychiatry 1997;
                                                                                       62:133-140.
60. Masdeu JC, Abdel-Dayem H, Van Heertum RL. Head trauma: use of
     SPECT. J Neuroimaging 1995;5(Suppl):S53-S57.                                 64. Kagi G, Bhatia KP, Tolosa E. The role of DAT-SPECT in movement disor-
                                                                                       ders. J Neurol Neurosurg Psychiatry 2010;81:5-12.
61. Hattori N, Swan M, Stobbe GA, et al. Differential SPECT activation pat-
     terns associated with PASAT performance may indicate frontocerebellar        65. Tatsch K. Imaging of the dopaminergic system in parkinsonism with
     functional dissociation in chronic mild traumatic brain injury. J Nucl Med        SPECT. Nucl Med Commun 2001;22:819-827.
     2009;50:1054-1061.
                                                                                  66. Darcourt J, Booji J, Tatsch K, et al. EANM procedure guidelines for brain
62. Peskind ER, Petrie EC, Cross DJ, et al. Cerebrocerebellar hypometabolism           neurotransmission SPECT using 123I-labelled dopamine transporter
     associated with repetitive blast exposure mild traumatic brain injury in 12       ligands, version 2. Eur J Nucl Med Mol Imaging 2010;37:443-450.
     Iraq war Veterans with persistent post-concussive symptoms. Neuroimage
     2011;54:S76-S82.
